Lumos Pharma (LUMO) Stock Chart & Stock Price History $4.34 0.00 (0.00%) (As of 12/12/2024) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Lumos Pharma Stock Price Performance 5 Day Performance0.00%1 Month Performance+0.46%3 Month Performance+13.02%6 Month Performance+92.04%Year-To-Date Performance+36.48%1 Year Performance+41.37% Receive LUMO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lumos Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover LUMO Stock Chart for Thursday, December, 26, 2024 LUMO Chart by TradingView Lumos Pharma Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/25/2024$4.34$4.34$4.39$4.33481,600 shs$37.54 million12/24/2024$4.34$4.34$4.39$4.33481,600 shs$37.54 million12/23/2024$4.34$4.34$4.39$4.33481,600 shs$37.54 million12/20/2024$4.34$4.34$4.39$4.33481,600 shs$37.54 million12/19/2024$4.34$4.34$4.39$4.33481,600 shs$37.54 million12/18/2024$4.34$4.34$4.39$4.33481,600 shs$37.54 million Get the Latest News and Ratings for LUMO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lumos Pharma and its competitors with MarketBeat's FREE daily newsletter. 12/17/2024$4.34$4.34$4.39$4.33481,600 shs$37.54 million12/16/2024$4.34$4.34$4.39$4.33481,600 shs$37.54 million12/12/2024$4.34$4.34$4.39$4.33481,600 shs$37.54 million12/11/2024$4.34$4.34$4.39$4.33481,687 shs$37.54 million12/10/2024$4.33$4.34+0.23%$4.34$4.32143,837 shs$37.54 million12/09/2024$4.33$4.33+0.12%$4.34$4.31122,014 shs$37.45 million12/06/2024$4.33$4.32-0.23%$4.35$4.32186,791 shs$37.36 million12/05/2024$4.32$4.33+0.23%$4.39$4.32122,863 shs$37.45 million12/04/2024$4.35$4.32-0.69%$4.38$4.32164,370 shs$37.37 million12/03/2024$4.38$4.35-0.68%$4.40$4.3543,001 shs$37.63 million12/02/2024$4.30$4.38+1.86%$4.40$4.31118,353 shs$37.88 million11/29/2024$4.30$4.30$4.33$4.3063,657 shs$37.20 million11/28/2024$4.30$4.30$4.34$4.30110,443 shs$37.19 million11/27/2024$4.32$4.30-0.46%$4.34$4.30110,443 shs$37.20 million11/26/2024$4.30$4.32+0.47%$4.38$4.3090,595 shs$37.37 million11/25/2024$4.31$4.30-0.23%$4.33$4.25259,602 shs$37.20 million Related Companies FitLife Brands Stock Chart Biomea Fusion Stock Chart InflaRx Stock Chart Nanobiotix Stock Chart Aligos Therapeutics Stock Chart Telomir Pharmaceuticals Stock Chart Instil Bio Stock Chart Puma Biotechnology Stock Chart Vaxart Stock Chart Enanta Pharmaceuticals Stock Chart Receive LUMO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lumos Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LUMO) was last updated on 12/26/2024 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredElon Musk could help pay for your retirementElon Musk is the richest man in the world... And he's pouring trillions into a unique investment.Brownstone Research | SponsoredTSLA *BANG* incoming (bullet in the chamber rn)I just pinpointed 5 dirt-cheap stocks that could soar the second the shot goes off. Thanks to Donald Trump’...StocksToTrade | SponsoredThe Key to Feeding 8.1 Billion PeopleImagine a mineral so small it fits in the palm of your hand... yet its potential could transform the world's f...i2i Marketing Group, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lumos Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lumos Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
